Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

7.8K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K
Tumor Progression02:07

Tumor Progression

3.5K
3.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.7K
1.7K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.5K
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel 3-Dimensional Printed Lock-and-Key Cutting Guide Mechanism for Single-Stage Customized Reconstruction After Skull Tumor Resection.

Operative neurosurgery (Hagerstown, Md.)·2026
Same author

Contemporary indications and outcomes of open surgical cerebral aneurysm management in the endovascular era.

Frontiers in surgery·2026
Same author

Focused ultrasound-mediated blood-brain barrier opening to enhance temozolomide delivery in glioblastoma: a systematic review of preclinical and early clinical evidence.

Neurosurgical review·2026
Same author

Symptomatic radiation necrosis following intracranial brachytherapy: a systematic review and meta-analysis.

Journal of neuro-oncology·2026
Same author

Neuro-Oncology Biotech Industry Progress Report 2025.

Cureus·2026
Same author

Pituitary Metastasis as the Initial Manifestation of an Undiagnosed Adenocarcinoma of Mullerian Origin: A Case Report and Literature Review.

International journal of surgical pathology·2026

Related Experiment Video

Updated: Mar 25, 2026

Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models
10:49

Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models

Published on: June 16, 2022

3.1K

Neuro-oncology biotech industry progress report.

Shamik Chakraborty1,2, Imithri Bodhinayake3, Amrit Chiluwal4

  • 1Brain Tumor Biotech Center, Feinstein Institute for Medical Research, Hofstra Northwell School of Medicine, Manhasset, NY, USA. chakrabs@gmail.com.

Journal of Neuro-Oncology
|February 22, 2016
PubMed
Summary

Researchers convened at the 2015 Brain Tumor Biotech Summit to discuss advancements in brain tumor treatment, focusing on novel therapies like stem cell targeting and innovative drug delivery systems.

Keywords:
BiotechnologyBrain tumorsGlioblastoma

More Related Videos

Implementation of Minimally Invasive Brain Tumor Resection in Rodents for High Viability Tissue Collection
08:23

Implementation of Minimally Invasive Brain Tumor Resection in Rodents for High Viability Tissue Collection

Published on: May 9, 2022

5.2K
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

28.0K

Related Experiment Videos

Last Updated: Mar 25, 2026

Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models
10:49

Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models

Published on: June 16, 2022

3.1K
Implementation of Minimally Invasive Brain Tumor Resection in Rodents for High Viability Tissue Collection
08:23

Implementation of Minimally Invasive Brain Tumor Resection in Rodents for High Viability Tissue Collection

Published on: May 9, 2022

5.2K
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

28.0K

Area of Science:

  • Neuro-oncology
  • Biotechnology
  • Medical Research

Background:

  • The Feinstein Institute for Medical Research hosted the 2015 Brain Tumor Biotech Summit.
  • The event aimed to foster collaboration among diverse stakeholders in brain tumor research and treatment.

Purpose of the Study:

  • To summarize recent advances in brain tumor research presented at the summit.
  • To highlight innovative therapeutic strategies and research directions.

Main Methods:

  • The summit featured presentations and discussions on various treatment modalities.
  • Key areas included stem cell targeting, EGFR inhibition, and novel drug delivery systems.

Main Results:

  • Advances in targeting brain tumor stem cells and the Epidermal Growth Factor Receptor (EGFR) were discussed.
  • Novel approaches such as prophage and immunostimulatory vaccines, retroviral vectors, biologic prodrugs, Cesium brachytherapy, and electric field therapy were presented.

Conclusions:

  • The summit underscored the importance of interdisciplinary collaboration in advancing brain tumor treatment.
  • Emerging therapies show promise for disrupting tumor cell proliferation and improving patient outcomes.